GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...

The Department of Veterans Affairs has started the process to designate multiple myeloma and acute and chronic leukemias as ...

"We know that clinical trials have recently been investigating the combination of teclistamab and daratumumab for multiple myeloma treatment," said SU2C ... getting rid of this amyloid buildup, which ...

Stand Up To Cancer® (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...